Pasatru
NDC 61755-012, garetosmab-grts, injection, solution, concentrate, from Regeneron Pharmaceuticals, Inc..
- Product NDC
- 61755-012
- Status
- Listed
- Labeler
- Regeneron Pharmaceuticals, Inc.
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761508
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/61755-012 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GARETOSMAB300 mg/5mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 61755-012-01 | 61755001201 | 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-012-01) / 5 mL in 1 VIAL, SINGLE-DOSE (61755-012-00) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/0d5cec96-b02b-4f1d-bc66-51e62ce04e3c
Use it
Look up 61755-012 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/61755-012 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 61755-012. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.